Cargando…
Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study
BACKGROUND AND OBJECTIVE: Long-term statin therapy has been shown to protect against several cancers, including esophageal cancer (EC). While the mechanisms underlying this effect are not clear. We investigated the effect of hydrophobic simvastatin and hydrophilic pravastatin on the proliferation of...
Autores principales: | Chen, Yan, Li, Li-Bin, Zhang, Jun, Tang, Du-Peng, Wei, Jing-Jing, Zhuang, Ze-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303879/ https://www.ncbi.nlm.nih.gov/pubmed/30579354 http://dx.doi.org/10.1186/s12944-018-0946-7 |
Ejemplares similares
-
Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C
por: Csomó, Krisztián, et al.
Publicado: (2022) -
Differential Effects of Pravastatin and Simvastatin on the Growth of Tumor Cells from Different Organ Sites
por: Menter, David G., et al.
Publicado: (2011) -
Pravastatin But Not Simvastatin Improves Survival and Neurofunctional Outcome After Cardiac Arrest and Cardiopulmonary Resuscitation
por: Bergt, Stefan, et al.
Publicado: (2017) -
Pravastatin inhibits cell proliferation and increased MAT1A expression in hepatocarcinoma cells and in vivo models
por: Hijona, Elizabeth, et al.
Publicado: (2012) -
Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)